SCHEMBL7057088

SCHEMBL7057088

c1csc(C2(CCN3CCCC3)C3CC4CC(C3)CC2C4)c1

nearest known ligand 0.39

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
SIGMAR1 Q99720 3/20 0.38
PRCP P42785 1/20 0.38
CHRM2 P08172 1/20 0.36
CHRM4 P08173 1/20 0.36
CHRM5 P08912 1/20 0.36
CHRM1 P11229 1/20 0.36
CHRM3 P20309 1/20 0.36
KCNH2 Q12809 1/20 0.34
HRH3 Q9Y5N1 1/20 0.34
HSD11B1 P28845 2/20 0.34
SLC6A2 P23975 1/20 0.33
OPRM1 P35372 2/20 0.33
OPRL1 P41146 2/20 0.33
CCR1 P32246 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7052677 0.99 SIGMAR1 (0.40) MEN1KMT2ASIGMAR1PRCPCHRM2
Hydrochloric Acid SCHEMBL7054114 0.99 MEN1 (0.38) MEN1KMT2ASIGMAR1PRCPCHRM2
SCHEMBL6682913 0.88 HTT (0.43) MEN1KMT2A
Hydrochloric Acid SCHEMBL6681764 0.87 ALDH1A1 (0.44) MEN1KMT2A
SCHEMBL6682839 0.79 HSD11B1 (0.39) MEN1KMT2ACHRM2CHRM4CHRM5
SCHEMBL6684471 0.79 SLC6A2 (0.41) CHRM2CHRM4CHRM5CHRM1CHRM3
Hydrochloric Acid SCHEMBL6680117 0.77 SLC6A2 (0.40) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL7082000 0.76 SLC6A2 (0.39) CHRM2CHRM4CHRM5CHRM1CHRM3
Hydrochloric Acid SCHEMBL7136533 0.75 SLC6A2 (0.38) CHRM2CHRM4CHRM5CHRM1CHRM3
Hydrochloric Acid SCHEMBL6894589 0.74 SLC6A2 (0.45) CHRM2CHRM4CHRM5CHRM1CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1305306-A2 2-ADAMANTYLETHYLAMINES AND THEIR USE IN THE TREATMENT OF CONDITIONS GENERALLY ASSOCIATED WITH ABNORMALITIES IN GLUTAMATERGIC TRANSMISSION VERNALIS RESEARCH LIMITED (GB) 2003-05-02 EP claimed
WO-2002008219-A2 2-ADAMANTYLETHYLAMINES AND THEIR USE IN THE TREATMENT OF CONDITIONS GENERALLY ASSOCIATED WITH ABNORMALITIES IN GLUTAMATERGIC TRANSMISSION VERNALIS RESEARCH LIMITED (GB) 2002-01-31 WO claimed